Post-finasteride Syndrome Foundation
Somerset, New Jersey
B-Health Score
50B-
Financial Health Score
8-metric score across financial health, operational efficiency, and resilience. Based on IRS Form 990 filing data.
Average
💰
$68K
Total Revenue
📊
$85K
Total Expenses
🏦
$17K
Net Assets
📋
N/A
Total Liabilities
Financial Trends
5-Year Trend Analysis
Financial Health Indicators
Revenue Growth
+36.3%
Year-over-year change (2022 → 2023)
Net Margin
-24.7%
Revenue minus expenses as % of revenue
Filing History
12 filings on record| Year | Revenue | Expenses | Assets | |
|---|---|---|---|---|
| 2023 | $67,901↑36% | $84,663↑104% | $16,960↓50% | |
| 2022 | $49,812↑244% | $41,418↓26% | $33,722↑33% | — |
| 2021 | $14,476↓83% | $55,855↑39% | $25,328↓81% | — |
| 2020 | $87,153↑150% | $40,158↓46% | $135,332↑53% | — |
| 2019 | $34,917↓82% | $74,642↓56% | $88,337↓31% | — |
| 2018 | $198,794↑141% | $169,227↑92% | $128,062↑30% | — |
| 2017 | $82,559↓47% | $88,138↓29% | $98,495↓5% | — |
| 2016 | $155,509↑379% | $123,539↑16% | $104,074↑44% | — |
| 2015 | $32,468↓92% | $106,845↓57% | $72,104↓51% | — |
| 2014 | $384,600↓22% | $248,021↓49% | $146,481↑145% | — |
| 2013 | $492,158↑272% | $489,620↑292% | $59,902↑713% | — |
| 2012 | $132,407 | $125,043 | $7,364 | — |
Frequently Asked Questions
What does Post-finasteride Syndrome Foundation do?▼
Post-finasteride Syndrome Foundation is a medical research nonprofit organization based in New Jersey. It is classified under NTEE code H90 and is registered as a 501(c) tax-exempt organization with the IRS.
Is Post-finasteride Syndrome Foundation financially healthy?▼
Financial health scoring requires Form 990 filing data. Check back as we process more filings for Post-finasteride Syndrome Foundation.
How much revenue does Post-finasteride Syndrome Foundation generate?▼
Post-finasteride Syndrome Foundation reports $91K in annual revenue and holds $32K in total assets, based on IRS filings.
Similar Organizations
Explore more organizations in the Medical Research category, or browse all nonprofits in New Jersey.